Access

Even when demand is real, awareness exists, relevance is clear, and trust is forming, one constraint remains.

Can you actually reach the people who decide?

Most candidates assume access is automatic. If they’re good enough, the process will find them. Recruiters know that access is uneven by design.

In pharma and biotech, where hiring involves layers, committees, and gatekeepers, access often determines who moves forward and who stalls.

Who actually influences the hiring decision?

Job searches are often framed as linear. Apply, interview, offer.

In reality, influence is distributed.

Recruiters screen. Hiring managers decide direction. Team members advise. Leadership approves. HR enforces process. Access means being visible to the people whose opinions carry weight, not just the system managing the process.

Candidates who only interact with the formal process often miss where real influence happens.

Are you only speaking to gatekeepers?

Gatekeepers matter, but they aren’t decision-makers.

Recruiters control flow, not outcomes. Their job is to manage risk and volume. Hiring managers decide whether a profile feels right. Access that stops at the recruiter level is often incomplete.

This is why some candidates feel liked by recruiters but never progress. The profile never truly reached the person who needed convincing.

In pharma, where hiring managers are often technical and time-poor, access requires intention.

Can your name move internally without you?

The strongest form of access is indirect.

When your name comes up in internal conversations without you being present, access compounds. Someone mentions you. Someone remembers you. Someone forwards your profile.

This usually happens through advocates: referrals, past colleagues, hiring managers who’ve already seen you, recruiters who trust you.

Candidates often try to manufacture access aggressively. The quieter form, being mentioned when decisions are discussed, is far more effective.

Are you depending on permission-based access?

Applications and formal outreach require permission.

You wait to be reviewed. You wait for feedback. You wait for next steps. Permission-based access moves at the system’s pace, not yours.

Non-permission-based access, introductions, conversations, warm messages, moves differently. It doesn’t bypass process, but it enters it at a different point.

In tight markets, where timing matters, that difference is decisive.

Do you understand how access narrows as processes advance?

Access shrinks over time.

Early stages are open. Later stages are guarded. Once shortlists form, new information struggles to enter. This is why late outreach often fails even when it’s strong.

Candidates who wait for rejection before seeking access usually act too late. Those who build access early benefit when decisions accelerate.

In pharma and biotech, where hiring cycles are long but decisions cluster suddenly, early access matters more than persistence.

Candidates often believe access is earned after proving themselves.

Recruiters know access often precedes evaluation.

If trust answers “is this safe?”

Access answers “can this person even be considered?”

Without access, strong profiles remain theoretical.